AKT1 and breast cancer: To determine if PL modulates AKT activity in breast cancer cells, MDA-MB-231 cells were treated with PL (0–1.0 mg ml−1) for 24 h and the phosphorylation status of AKT evaluated in whole-cell extracts by western blot analysis.